Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance

DG Hernandez, X Reed… - Journal of …, 2016 - Wiley Online Library
Parkinson's disease is a common, progressive neurodegenerative disorder, affecting 3% of
those older than 75 years of age. Clinically, Parkinson's disease (PD) is associated with …

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

N Exner, AK Lutz, C Haass, KF Winklhofer - The EMBO journal, 2012 - embopress.org
Neurons are critically dependent on mitochondrial integrity based on specific morphological,
biochemical, and physiological features. They are characterized by high rates of metabolic …

Structure of LRRK2 in Parkinson's disease and model for microtubule interaction

CK Deniston, J Salogiannis, S Mathea, DM Snead… - Nature, 2020 - nature.com
Leucine-rich repeat kinase 2 (LRRK2) is the most commonly mutated gene in familial
Parkinson's disease and is also linked to its idiopathic form. LRRK2 has been proposed to …

LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network

Z Liu, N Bryant, R Kumaran, A Beilina… - Human molecular …, 2018 - academic.oup.com
Human genetic studies implicate LRRK2 and RAB7L1 in susceptibility to Parkinson disease
(PD). These two genes function in the same pathway, as knockout of Rab7L1 results in …

Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations

Z Sheng, S Zhang, D Bustos, T Kleinheinz… - Science translational …, 2012 - science.org
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common cause of
familial Parkinson's disease (PD). Although biochemical studies have shown that certain PD …

Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice

M Yue, KM Hinkle, P Davies, E Trushina, FC Fiesel… - Neurobiology of …, 2015 - Elsevier
Mutations in the LRRK2 gene represent the most common genetic cause of late onset
Parkinson's disease. The physiological and pathological roles of LRRK2 are yet to be fully …

LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1

X Wang, MH Yan, H Fujioka, J Liu… - Human molecular …, 2012 - academic.oup.com
The leucine-rich repeat kinase 2 (LRRK2) mutations are the most common cause of
autosomal-dominant Parkinson disease (PD). Mitochondrial dysfunction represents a critical …

The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

MR Cookson - Nature Reviews Neuroscience, 2010 - nature.com
Parkinson's disease, like many common age-related conditions, is now recognized to have a
substantial genetic component. Here, I discuss how mutations in a large complex gene …

14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization

RJ Nichols, N Dzamko, NA Morrice… - Biochemical …, 2010 - portlandpress.com
LRRK2 (leucine-rich repeat protein kinase 2) is mutated in a significant number of
Parkinson's disease patients, but still little is understood about how it is regulated or …

Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization

N Dzamko, M Deak, F Hentati, AD Reith… - Biochemical …, 2010 - portlandpress.com
LRRK2 (leucine-rich repeat protein kinase 2) is mutated in a significant number of
Parkinson's disease patients. Since a common mutation that replaces Gly2019 with a serine …